Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other 116Head & Neck 51Other hematologic neoplasm 13Lymphoid 8Plasma cell 7Gastrointestinal 5Sarcoma 4Genitourinary 3Classical hematology 3Myeloid 2CNS 2Breast 2Thoracic 1Endocrine 1

Conditions

Breast Neoplasms 10163Triple Negative Breast Neoplasms 1042Neoplasms 572Ovarian Neoplasms 560Neoplasm Metastasis 513Colorectal Neoplasms 467Carcinoma, Non-Small-Cell Lung 465Prostatic Neoplasms 439Lung Neoplasms 432Pancreatic Neoplasms 312Melanoma 299Stomach Neoplasms 294Breast Neoplasms, Male 257Motor Activity 252Colonic Neoplasms 238Uterine Cervical Neoplasms 225Endometrial Neoplasms 221Head and Neck Neoplasms 217Carcinoma, Intraductal, Noninfiltrating 217Carcinoma, Renal Cell 191Squamous Cell Carcinoma of Head and Neck 179Sarcoma 175Urinary Bladder Neoplasms 159Brain Neoplasms 155Esophageal Neoplasms 154Breast Carcinoma In Situ 154Lymphedema 148Fatigue 136Carcinoma, Ovarian Epithelial 134Small Cell Lung Carcinoma 128

Interventions

Everolimus 1Alginates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Mucositis × Breast × Clear all
NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation
90 enrolled
BreastOther

Breast Neoplasms, Esophagitis, Mucositis

NCT02273752 2017-02-03

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Emory University

Phase 2 Terminated
2 enrolled 5 charts
BreastEndocrineGenitourinaryOther

Breast Neoplasms, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡